Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Cipher Pharmaceuticals
Cipher Pharmaceuticals
(CPHR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Conzip
Tramadol
2010-05-07
2030-2040
Pain
,
Fever
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Osteoarthritis
,
Adenomatous polyposis coli
,
Dysmenorrhea
Lipofen
Fenofibrate
2006-01-11
2024-2033
Hypercholesterolemia
,
Coronary artery disease
,
Dyslipidemias
,
Hypertriglyceridemia
,
Hyperlipoproteinemias
Natroba
Spinosad
2011-01-18
2023-2033
Lice infestations
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Tramadol
healthy volunteers/patients
Trinessa
healthy volunteers/patients
Mydfrin
healthy volunteers/patients
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use